Hydrogen Bromide → HCID 178419707、化合物

HRID 1063935

反応式

HRID 1063935 の反応式
[CH2:1]1[C@H:6]([NH2:7])[C@@H:5]([O:8][C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2N)[C@H:4]([O:20][C@@H]2O[C@H](CO)[C@@H](O[C@H]3O[C@@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@H]2O)[C@@H:3]([OH:41])[C@@H:2]1[NH2:42].OS(O)(=O)=O.[BrH:48]>>[CH2:1]1[C@H:2]([NH2:42])[C@@H:3]([OH:41])[C@H:4]([OH:20])[C@@H:5]([OH:8])[C@@H:6]1[NH2:7].[BrH:48]

参加物

3

反応条件

温度
100 °C

実験手順

A solution of neomycin sulfate (20 g, 20.8 mmol) in HBr (150 mL, 48%) is stirred under reflux at 100° C. for 40 hours. The solution is concentrated to dryness at 60° C. under reduced pressure. The residue is dissolved into water (H2O) (100 mL), and activated charcoal (10 g) is added. After stirring at room temperature for 10 hours, the charcoal is removed by filtration through Celite, and the solution is concentrated to a syrup. Methanol (100 mL) is added and the mixture is stirred for 2 hours t room temperature. The solid product is filtered to give 2-deoxystreptamine hydrobromide 3 (4.1 g, 61%). Rf: 0.2 (CH3OH/NH4OH=4:1); 1H-NMR (D2O, 200 MHZ): d 1.95 (1H, ddd), 2.5 (1H, m), 3.2-3.6 (9H, m); 13C-NMR (D2O, 200 MHZ): d 40.0, 65.0, 87.2, 89.5.

後処理

  1. concentrationThe solution is concentrated to dryness at 60° C. under reduced pressure
  2. dissolutionThe residue is dissolved into water (H2O) (100 mL), and activated charcoal (10 g)
  3. additionis added
  4. customthe charcoal is removed by filtration through Celite
  5. concentrationthe solution is concentrated to a syrup
  6. additionMethanol (100 mL) is added
  7. stirringthe mixture is stirred for 2 hours t room temperature
  8. filtrationThe solid product is filtered

出典と根拠

ORDレコード
ord-39472f93fbe248d9a080374fb2535f94
出典データセット
uspto-grants-2005_11
特許番号
US06967242B2

関連ノート

読み込み中…